AR

Arul Raja Austin Louis Raja

Active Director Director DIN 09859458
DIN 09859458 First appointment Jan 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Arul Raja Austin Louis Raja

Data last updated:

Arul Raja Austin Louis Raja is a Director at Messiah Bio Gen Private Limited (since 2023). The company operates in Pharma.

DIN 09859458
Primary Designation Director
Industry Pharma
First Appointment 12 Jan 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Messiah Bio Gen Private Limited U24304TN2023PTC158249
Director12 Jan 20232023Active

Board colleagues of Arul Raja Austin Louis Raja

Directorship timeline

Open interactive timeline →
Messiah Bio Gen Private Limited
Premium access

Shareholding and investment profile for Arul Raja Austin Louis Raja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arul Raja Austin Louis Raja

Arul Raja Austin Louis Raja currently holds 1 directorship: Messiah Bio Gen Private Limited (Director, since 12 Jan 2023).

Arul Raja Austin Louis Raja was first appointed on 12 Jan 2023 as Director at Messiah Bio Gen Private Limited.

The current boards of Arul Raja Austin Louis Raja's companies include Anita Soris Bennet Soris (Messiah Bio Gen Private Limited), Arul Raja (Messiah Bio Gen Private Limited), Joseph Bennet Soris (Messiah Bio Gen Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available